Qiagen

Summary

Qiagen appeared to be the Corporate Investor, which was created in 1986. The fund was located in Europe if to be more exact in The Netherlands. The main office of represented Corporate Investor is situated in the Venlo.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Qiagen, startups are often financed by S-Venture Capital Dortmund, NGN Capital, Forbion Capital Partners. The meaningful sponsors for the fund in investment in the same round are NGN Capital, Forbion Capital Partners, Arcus Ventures. In the next rounds fund is usually obtained by Techno Venture Management, NGN Capital, Forbion Capital Partners.

The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2019. The high activity for fund was in 2014. Opposing the other organizations, this Qiagen works on 28 percentage points more the average amount of lead investments. Speaking about the real fund results, this Corporate Investor is 23 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Exosome Diagnostics, Ingenium Pharmaceuticals AG, Xagenic. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Health Care, Manufacturing.